Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapy

Lior H. Katz, Abigail Fraser, Leonard Leibovici, Ran Tur-Kaspa, Hadar Goldvaser

Research output: Contribution to journalComment/debate

Original languageEnglish
Article numberCD005264
JournalCochrane Database of Systematic Reviews
Issue number9
StatePublished - 12 Sep 2019

Cite this